Clovis oncology, inc. (CLVS)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11
ASSETS
Current assets:
Cash and cash equivalents

163,309

161,833

201,481

108,607

123,308

221,876

290,853

468,321

374,114

464,198

611,472

491,786

276,049

216,186

243,724

228,379

220,373

278,756

355,443

236,261

291,542

482,677

516,585

273,232

303,654

323,228

356,624

372,240

129,634

144,097

162,479

176,903

120,983

138,236

Accounts receivable, net

25,081

20,562

16,816

15,375

16,096

12,889

14,495

12,304

12,936

6,181

-

1,143

2,378

121

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Insurance receivable

-

-

-

-

-

-

-

-

-

-

25,000

25,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories, net

30,600

26,519

24,900

26,600

24,986

27,072

43,682

62,989

69,192

27,508

5,345

6,478

6,504

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Available-for-sale securities

65,051

134,826

152,622

207,306

283,474

298,270

313,525

213,921

89,697

99,533

16,499

179,744

132,778

49,997

75,054

150,122

225,117

249,832

250,444

141,382

141,833

-

-

-

-

-

-

-

-

-

0

-

0

2,012

Prepaid research and development expenses

2,656

3,881

4,597

3,498

3,761

3,579

2,907

2,723

4,619

1,559

2,853

4,854

5,465

6,427

7,376

14,477

10,391

3,377

2,394

3,114

3,072

3,765

2,241

581

866

976

1,167

605

234

116

443

596

542

1,020

Deposit on inventory

-

-

-

-

-

-

13,514

0

-

20,461

31,818

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current assets

14,671

18,847

18,095

17,377

15,452

8,613

11,780

8,360

9,115

7,500

5,911

6,766

5,645

6,679

5,194

6,559

8,090

7,736

7,159

7,440

5,257

4,730

7,925

5,830

4,817

4,392

727

598

524

659

378

419

650

247

Total current assets

301,345

366,468

418,475

378,744

467,077

572,299

690,756

768,618

559,673

626,940

698,898

715,771

428,819

279,410

331,348

399,537

463,971

539,701

615,440

388,197

441,704

491,172

526,751

279,643

309,337

328,596

358,518

373,443

130,392

144,872

163,300

177,918

122,175

141,515

Inventories

87,300

98,053

97,200

107,700

114,996

113,908

20,005

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposit on inventory

24,723

12,350

12,350

12,350

12,350

12,350

31,119

53,937

9,303

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

14,285

15,287

15,223

15,802

16,193

26,524

11,035

5,696

3,938

4,007

4,070

4,155

4,226

4,440

4,707

4,974

5,108

4,946

3,303

3,333

3,316

2,718

2,846

1,298

1,113

955

988

1,030

1,069

1,084

1,981

1,944

2,003

1,896

Right-of-use assets, net

26,550

28,141

25,427

22,383

23,919

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

61,708

62,920

64,132

65,343

65,810

51,930

52,709

53,480

19,189

19,561

19,932

20,304

20,675

21,047

-

-

105,689

101,500

196,390

195,976

187,916

212,900

220,723

239,215

241,511

244,518

-

-

-

-

-

-

-

-

Goodwill

63,074

63,074

63,074

63,074

63,074

63,074

63,074

63,475

66,960

65,217

64,253

62,018

58,015

57,192

60,748

60,606

61,775

59,327

60,932

60,804

58,303

66,055

68,482

74,219

74,931

74,811

-

-

-

-

-

-

-

-

Other assets

22,841

23,311

20,990

20,609

21,198

23,475

22,766

22,526

19,861

19,505

18,206

47,648

24,879

2,468

1,821

2,868

8,031

7,912

15,624

14,694

13,470

4,541

12,725

4,507

2,499

755

753

751

36

38

38

37

35

34

Total assets

601,793

669,604

716,892

685,975

784,617

863,560

891,464

967,732

678,924

735,230

805,359

849,896

536,614

364,557

398,624

467,985

644,574

713,386

891,689

663,004

704,709

777,386

831,527

598,882

629,391

649,635

360,259

375,224

131,497

145,994

165,319

179,899

124,213

143,445

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities:
Accounts payable

36,201

32,237

31,655

18,503

43,288

28,517

30,501

15,900

13,378

15,147

14,308

13,360

23,918

10,912

11,076

15,008

14,100

11,260

9,316

5,525

7,373

2,917

2,428

2,891

2,796

4,420

880

1,589

3,841

2,297

2,123

1,401

2,477

3,036

Accrued research and development expenses

46,573

53,214

43,981

34,637

33,303

29,676

21,259

19,788

22,224

18,465

21,344

21,158

25,868

35,198

36,088

46,337

52,642

53,011

58,954

48,395

44,547

37,257

23,832

18,809

19,247

12,548

10,916

8,199

6,013

7,161

7,577

6,570

5,857

5,071

Lease liabilities

5,389

5,405

4,458

4,332

4,253

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

2,755

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Milestone liability

-

-

-

-

-

-

0

0

22,534

22,022

21,511

21,011

20,528

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liability for legal settlement

-

-

-

21,000

-

-

-

20,000

-

-

142,000

142,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other accrued expenses

34,060

42,228

31,266

27,626

25,578

67,556

24,732

20,928

27,306

25,883

17,467

21,848

9,083

19,487

11,906

11,511

7,199

11,305

7,667

8,508

3,764

7,598

4,719

3,274

2,113

3,984

2,783

2,224

1,636

2,702

2,331

1,876

1,341

2,889

Total current liabilities

122,223

133,084

111,360

106,098

106,422

125,749

76,492

76,616

85,442

81,517

219,385

219,377

58,869

65,597

59,070

72,856

73,941

75,576

75,937

62,428

55,684

47,772

30,979

24,974

24,156

20,952

14,579

12,012

11,490

12,160

12,031

9,847

9,675

10,996

Long-term lease liabilities - less current portion

27,734

29,479

27,768

24,946

26,047

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Milestone liability

-

-

-

-

-

-

-

-

-

-

-

-

-

20,062

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent purchase consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

25,710

24,661

52,421

51,575

49,659

52,453

55,445

57,172

56,630

55,754

-

-

-

-

-

-

-

-

Deferred income taxes

-

-

-

-

-

-

-

-

371

-

421

632

207

-

266

333

30,476

31,133

61,138

61,537

59,006

66,851

69,307

75,113

75,835

74,955

-

-

-

-

-

-

-

-

Convertible senior notes

524,905

644,751

644,095

576,763

576,003

575,470

574,828

574,335

282,732

282,406

282,082

281,761

281,443

281,126

280,813

280,501

280,192

279,885

287,500

287,500

287,500

278,680

287,500

-

-

-

-

-

-

-

-

-

-

-

Borrowings under financing agreement

52,419

34,991

19,944

6,893

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

1,506

1,556

1,220

1,257

1,294

15,872

6,478

4,431

4,143

3,671

4,282

4,333

1,358

1,406

1,437

1,463

1,592

1,481

371

290

271

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

17

26

88

-

-

-

338

-

-

-

-

Total liabilities

728,787

843,861

804,387

715,957

709,766

717,091

657,798

655,382

372,688

367,594

506,170

506,103

362,405

368,191

341,586

355,153

411,911

412,736

477,367

463,330

452,120

445,756

443,237

157,276

156,647

151,749

-

-

-

12,498

-

-

-

-

Non-current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

150

211

270

-

408

484

555

656

Commitments and contingencies (Note 13)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized, no shares issued and outstanding at March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.001 par value per share, 200,000,000 shares authorized at March 31, 2020 and December 31, 2019, respectively; 73,496,587 and 54,956,341 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

73

55

55

53

53

53

53

53

51

51

49

49

45

39

39

39

38

38

38

34

34

34

34

34

34

34

30

30

26

26

26

26

22

22

Additional paid-in capital

2,260,671

2,114,068

2,101,162

2,064,393

2,048,875

2,034,142

2,021,997

2,010,311

1,899,624

1,887,198

1,767,397

1,752,943

1,410,789

1,174,950

1,162,324

1,152,463

1,141,648

1,129,978

1,118,135

805,269

795,019

785,089

778,700

773,206

767,226

762,170

585,243

582,415

319,817

317,899

316,222

314,650

243,408

242,221

Accumulated other comprehensive loss

-44,890

-44,865

-44,699

-44,488

-44,564

-44,634

-44,550

-44,045

-40,661

-42,173

-42,701

-44,306

-47,118

-47,580

-45,010

-45,050

-43,717

-47,460

-41,486

-41,909

-50,275

-24,448

-16,306

2,862

5,216

4,696

68

47

44

53

55

47

51

49

Accumulated deficit

-2,342,848

-2,243,515

-2,144,013

-2,049,940

-1,929,513

-1,843,092

-1,743,834

-1,653,969

-1,552,778

-1,477,440

-1,425,556

-1,364,893

-1,189,507

-1,131,043

-1,060,315

-994,620

-865,306

-781,906

-662,365

-563,720

-492,189

-429,045

-374,138

-334,496

-299,732

-269,014

239,811

219,491

200,150

184,482

163,423

145,155

129,498

110,499

Total stockholders' deficit

-126,994

-174,257

-87,495

-29,982

74,851

146,469

233,666

312,350

306,236

367,636

299,189

343,793

174,209

-3,634

57,038

112,832

232,663

300,650

414,322

199,674

252,589

331,630

388,290

441,606

472,744

497,886

345,530

363,001

119,737

133,496

152,880

169,568

113,983

131,793

Total liabilities and stockholders' equity (deficit)

601,793

669,604

716,892

685,975

784,617

863,560

891,464

967,732

678,924

735,230

805,359

849,896

536,614

364,557

398,624

467,985

644,574

713,386

891,689

663,004

704,709

777,386

831,527

598,882

629,391

649,635

360,259

375,224

131,497

145,994

165,319

179,899

124,213

143,445